CLINICAL STUDY ON AKKARAM (STOMATITIS) WITH SIDDHA DRUG "KATRALAIYATHI THYLAM"(INTERNAL)IN CHILDREN.

Phase II Non Randomized clinical study on Akkaram (stomatitis) with the evaluation of siddha trial drug katralaiyathi thylam (internal) in children - nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/02/063213

Enrollment

Registered

2024-02-27

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K121- Other forms of stomatitis

Interventions

Intervention1: Katralaiyathi thylam (internal): Katralaiyathi thylam 3-5ml twice a day for 7-14 days Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: all gender ulceration in the oral cavity Blisters in the mouth foul smelling breath fever

Exclusion criteria

Exclusion criteria: ottis media sinusitis oral ulcer due to cancer acute catarrhal rhinitis Herpetic giginvostomitis

Design outcomes

Primary

Measure	Time frame
It is assessed by reduction in symptoms and WHO Oral Mucositis scale. Timepoint: 14 days	—

Secondary

Measure	Time frame
It is assessed by comparing the safety parameters of trial drug Katralaiyathi thylam before and after Treatment.Timepoint: 14 days	—

Countries

India

Contacts

Public ContactDr Dharani M

Government siddha medical college,chennai

cspriya2004@gmail.com9445661808

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026